Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2023-07-07 Regulatory Filings
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-07-07 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying the closure of the trading window in compliance with SEBI regulations ahead of the announcement of quarterly financial results. It does not contain any financial data or results itself, nor does it present a report. Instead, it is an announcement related to insider trading restrictions prior to the release of the quarterly results. The document length is short (1735 characters), and it serves as a regulatory compliance notification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2023-06-29 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the proceedings and results of a Postal Ballot conducted by the company. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Companies Act, 2013. The document details the voting results on special resolutions, including re-appointment of a director and approval of loans/guarantees. It is not a full annual or interim report, nor an earnings release or management discussion. It is not a proxy solicitation or AGM presentation but specifically the official announcement of voting results from a shareholder postal ballot. The document is lengthy (9553 characters) and contains detailed voting data and resolution outcomes, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-06-27 English
Shareholders meeting
Regulatory Filings
2023-06-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (National Stock Exchange of India and Bombay Stock Exchange) informing them about the schedule of analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30 related to disclosure of events or information. The content is about announcing upcoming investor meetings, not a financial report, earnings release, or any detailed financial data. The document length is short (1571 characters), and it is an announcement of a meeting schedule rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-06-23 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a notice addressed to stock exchanges regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF). It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations and includes copies of newspaper advertisements. The document is short (1516 characters) and serves as an announcement rather than a detailed report or financial statement. It does not contain financial data, management discussion, or audit information. It is an official regulatory announcement related to share transfers and compliance disclosures, fitting best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-06-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.